Fig. 3From: Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohortSubanalysis of OS according to ECOG PS (a) and treatment line (b). Marks on the curve indicate patients who were censoredBack to article page